Potato Cell Or Cell Line, Per Se Patents (Class 435/417)
-
Patent number: 12209259Abstract: DNA cleaving enzymes are disclosed. The DNA cleaving enzymes are fused to a heterologous DNA binding domain that is designed to bind to a target nucleic acid sequence. Nucleic acids and expression cassettes encoding the DNA cleaving enzymes are also provided. Methods for genome editing using the DNA cleaving enzymes, fusion proteins, and compositions thereof are disclosed herein.Type: GrantFiled: June 26, 2019Date of Patent: January 28, 2025Assignee: Altius Institute for Biomedical SciencesInventors: John A. Stamatoyannopoulos, Fyodor Urnov, Jocelynn Pearl, Sean Thomas
-
Patent number: 12065654Abstract: The present invention refers to a method for controlling undesired vegetation at a plant cultivation site, the method comprising the steps of providing, at said site, a plant that comprises at least one nucleic acid comprising a nucleotide sequence encoding a wild-type hydroxyphenyl pyruvate dioxygenase or a mutated hydroxyphenyl pyruvate dioxygenase (mut-HPPD) which is resistant or tolerant to a HPPD-inhibiting herbicide and/or a nucleotide sequence encoding a wild-type homogentisate solanesyl transferase or a mutated homogentisate solanesyl transferase (mut-HST) which is resistant or tolerant to a HPPD-inhibiting herbicide, applying to said site an effective amount of said herbicide. The invention further refers to plants comprising mut-HPPD, and methods of obtaining such plants.Type: GrantFiled: May 21, 2021Date of Patent: August 20, 2024Assignee: BASF SEInventors: Maciej Pasternak, Stefan Tresch, Johannes Hutzler, Jens Lerchl, Thomas Mietzner, Brigitte Weston, Matthias Witschel, Jill Paulik
-
Patent number: 12060424Abstract: The present invention relates to activatable recombinant polypeptide compositions comprising a cleavage release segment. In some instances, the activatable recombinant polypeptide compositions include an XTEN linked to binding moieties by cleavable release segments that, when cleaved, the binding moieties are capable of binding together effector T cells with targeted tumor or cancer cells and effecting cytolysis of the tumor cells or cancer cells. The invention also provides compositions and methods of making and using the cleavable activatable recombinant compositions.Type: GrantFiled: December 20, 2018Date of Patent: August 13, 2024Assignee: AMUNIX PHARMACEUTICALS, INC.Inventors: Fan Yang, Volker Schellenberger, Vladimir Podust, Bee-Cheng Sim, Desiree Thayer, John Beaber
-
Patent number: 11678668Abstract: The present disclosure provides non-intergeneric remodeled microbes that are able to fix atmospheric nitrogen and deliver such to plants in a targeted, efficient, and environmentally sustainable manner. The utilization of the taught microbial products will enable farmers to realize more productive and predictable crop yields without the nutrient degradation, leaching, or toxic runoff associated with traditional synthetically derived nitrogen fertilizer. The remodeled microbes taught herein are able to be combined with leading agricultural chemistry and elite germplasm. Furthermore, the disclosure provides seed treatments comprising remodeled microbes.Type: GrantFiled: January 14, 2022Date of Patent: June 20, 2023Assignee: PIVOT BIO, INC.Inventors: Mark Reisinger, Ernest Sanders, Richard Broglie, Karsten Temme
-
Patent number: 11597770Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to E-selectin. The invention includes uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.Type: GrantFiled: January 21, 2021Date of Patent: March 7, 2023Assignee: Pfizer Inc.Inventors: James Reasoner Apgar, Sheryl Rubio Bowley, Joanne Elizabeth-Ayriss Elwell, Laura Lin, Jatin Narula, Chuenlei Parng, Debra Denene Pittman, Swapnil Rakhe, Chihyi Vincent Yu
-
Patent number: 11542516Abstract: Recombinant DNA molecules and constructs including sequences derived from Tripsacum dactyloides are provided, which are useful for modulating gene expression in plants. Transgenic plants, plant cells, plant parts, and seeds are also provided, comprising a recombinant DNA molecule operably linked to a heterologous transcribable DNA molecule, as well as methods of their use.Type: GrantFiled: August 14, 2019Date of Patent: January 3, 2023Assignee: MONSANTO TECHNOLOGY, LLCInventors: Stanislaw Flasinski, Jun Zhang, Suling Zhao
-
Patent number: 10143176Abstract: A new and distinct clonal line plant of Solanum tuberosum L. named KI964 and characterized by elevated levels of proteinase inhibitor II.Type: GrantFiled: December 8, 2016Date of Patent: December 4, 2018Assignee: KEMIN INDUSTRIES, INC.Inventors: Brindha Narasimhamoorthy, Liuqing Zhao, Xin Liu, John A. Greaves
-
Patent number: 10130066Abstract: A new and distinct clonal line plant of Solanum tuberosum L. named KI969 and characterized by elevated levels of proteinase inhibitor II.Type: GrantFiled: December 8, 2016Date of Patent: November 20, 2018Assignee: KEMIN INDUSTRIES, INC.Inventors: Brindha Narasimhamoorthy, Liuqing Zhao, Xin Liu, John A. Greaves
-
Patent number: 9523097Abstract: The present invention relates to transplastomic guayule plants comprising chloroplasts engineered to express the complete cytosolic mevalonic acid (MEV) pathway.Type: GrantFiled: March 13, 2014Date of Patent: December 20, 2016Assignee: The United States of America, as represented by the Secretary of AgricultureInventors: Byung-Guk Kang, Colleen M McMahan, Maureen C Whalen, Niu Dong, Shashi Kumar
-
Publication number: 20150096070Abstract: The present invention provides novel promoters for use in plants. Specifically, the present invention provides novel chimeric promoters comprising combinations of plant viral enhancer elements and plant promoters. The present invention also provides DNA constructs; transgenic cells, plants, and seeds containing these novel chimeric promoters; and methods for preparing and using the same.Type: ApplicationFiled: November 25, 2014Publication date: April 2, 2015Inventor: STANISLAW FLASINSKI
-
Publication number: 20150096083Abstract: The present invention provides non-coding regulatory element polynucleotide molecules isolated from the lipid transfer protein (LTP) gene of Oryza sativa and useful for expressing transgenes in plants. The invention further discloses compositions, polynucleotide constructs, transformed host cells, transgenic plants and seeds containing the Oryza sativa regulatory polynucleotide sequences, and methods for preparing and using the same.Type: ApplicationFiled: July 28, 2014Publication date: April 2, 2015Inventors: Wei Wu, Qi Wang, James Morrell, Linda Lutfiyya, Maolong Lu, Zhaolong Li, Ping Li, Michelle Lacy, David Kovalic, Yongwei Cao, Andrey Boukharov, Stanislaw Flasinski, Peter T. Hajdukiewicz
-
Publication number: 20150082485Abstract: The present invention is drawn to novel genes from wild plants, such as wild potato and pepper plants, that confer potyvirus resistance to plants, such as in transformed cultivated plants. Also encompassed are cultivated plants transformed with the novel gene, food products made from the transformed cultivated plants, and methods for making such plants and food products.Type: ApplicationFiled: November 25, 2014Publication date: March 19, 2015Inventors: Caius Rommens, Hui Duan, Rekha Chawla
-
Publication number: 20150082495Abstract: The present invention relates to control of plant pathogens, particularly fungi or oomycetes, by inhibiting one or more biological functions, particularly by inhibiting saccharopine dehydrogenase gene(s) using RNA interference. The invention provides methods and compositions using RNA interference of plant pathogens target genes for such control. The invention is also directed to methods for making transgenic plants tolerant to said plant pathogens, and to transgenic plants and seeds generated thereof.Type: ApplicationFiled: October 3, 2012Publication date: March 19, 2015Applicant: Bayer Intellectual Property GmbHInventors: Thomas Delebarre, Cécile Dorme, Bernd Essigmann, Frédéric Schmitt, François Villalba, Eric Paget
-
Publication number: 20150067923Abstract: Plant genes regulated by transcription factors that control the gene network response to an environmental perturbation or signal are described. This class of genes responds to the perturbation of a transcription factor and the signal it transduces, but surprisingly, without stable binding of the transcription factor. These genes represent members of the “dark matter” of metabolic regulatory circuits. The invention involves the transgenic manipulation of these “response genes” and/or the genes encoding their regulatory transcription factors in plants so that their respective gene products are either overexpressed or underexpressed in the plant in order to confer a desired phenotype. The invention also relates to a rapid technique named “TARGET” (Transient Assay Reporting Genome-wide Effects of Transcription factors) for determining such “response genes” and their transcription factors by perturbation of the expression of the transcription factors of interest in protoplasts of any plant species.Type: ApplicationFiled: August 12, 2014Publication date: March 5, 2015Applicant: New York UniversityInventors: Gloria Coruzzi, Kenneth Birnbaum, Bastiaan Bargmann, Gabriel Krouk
-
Publication number: 20150047076Abstract: The present invention provides novel insecticidal proteins active against a Coleopteran and/or Hemipteran species pest, which include, but are not limited to, TIC3131, TIC3400 and TIC3407 proteins. The present invention also provides a DNA construct comprising operably linked to a heterologous promoter a polynucleotide that encodes the novel insecticidal protein or an insecticidal fragment thereof. The present invention further provides transgenic plants/plant cells/plant parts expressing the insecticidal proteins, methods for detecting the presence of the polynucleotide or the protein in a biological sample, and methods of controlling a Coleopteran and/or Hemipteran species pest using the insecticidal proteins.Type: ApplicationFiled: August 8, 2014Publication date: February 12, 2015Applicant: Monsanto Technology LLCInventors: Heather M. Anderson, David J. Bowen, Catherine A. Chay, Stanislaw Flasinski, Uma R. Kesanapalli, Jason S. Milligan, Rachael N. Slightom, Yong Yin
-
Publication number: 20150023967Abstract: The present invention relates to a binding molecule which is at least bispecific comprising a first and a second binding domain, wherein the first binding domain is capable of binding to epitope cluster3 of BCMA, and the second binding domain is capable of binding to the Tcell CD3 receptor complex. Moreover, the invention provides a nucleic acid sequence encoding the binding molecule, a vector comprising said nucleic acid sequence and a host cell transformed or transfected with said vector. Furthermore, the invention provides a process for the production of the binding molecule of the invention, a medical use of said binding molecule and a kit comprising said binding molecule.Type: ApplicationFiled: November 15, 2012Publication date: January 22, 2015Inventors: Peter Kufer, Tobias Raum, Patrick Hoffmann, Roman Kischel, Ralf Lutterbuese, Doris Rau, Paul Adam, Eric Borges, Barbara Hebeis, Susanne Hipp
-
Publication number: 20150024009Abstract: The invention provides an isolated genetically modified non-mammalian organism, wherein the activity of acyl-CoA:sterol acyltransferase/sterol O-acyltransferase (EC 2.3.1.26) and/or diacylglycerol acyltransferase/diacylglycerol O-acyltranferase (EC 2.3.1.20) and/or lecithin cholesterol acyl transferase/phospholipid: diacylglycerol acyltransferase (EC 2.3.1.158) and/or acyl CoA-wax alcohol acyltransferase (EC 2.3.1.75) is reduced or abolished in comparison with a corresponding wildtype organism, methods of use of such an organism, shuttle vehicles for making such an organism and methods for producing such an organism.Type: ApplicationFiled: September 19, 2014Publication date: January 22, 2015Applicant: ORGANOBALANCE GMBHInventors: Christine Lang, Andreas Raab
-
Publication number: 20150020241Abstract: The present invention provides non-coding regulatory element polynucleotide molecules isolated from the S-adenosyl methionine synthetase (SAMS3) gene of Arabidopsis thaliana and useful for expressing transgenes in plants. The invention further discloses compositions, polynucleotide constructs, transformed host cells, transgenic plants and seeds containing the Arabidopsis thaliana regulatory polynucleotide sequences, and methods for preparing and using the same.Type: ApplicationFiled: June 6, 2014Publication date: January 15, 2015Inventors: Wei Wu, Qi Wang, Michael Edgerton, Kim Beazley, Jill Deikman, Michael W. Petersen, Bei Zhang
-
Publication number: 20150020242Abstract: A novel promoter useful for altering the color of flowers of a plant, which is selected from the group consisting of: (1) a nucleic acid which comprises the nucleotide sequence represented by SEQ ID NO: 20, SEQ ID NO: 12 or SEQ ID NO: 21; and (2) a nucleic acid which maintains the same promoter activity as that of the nucleotide sequence represented by SEQ ID NO: 20, SEQ ID NO: 12 or SEQ ID NO: 21, and which comprises a nucleotide sequence that is produced by modifying the original nucleotide sequence by the addition, deletion and/or substitution of one or several nucleotide sequences, or can hybridize with a nucleotide acid comprising a nucleotide sequence complementary to the original nucleotide sequence under highly stringent conditions, or has a 90% or more sequence identity to the original nucleotide sequence.Type: ApplicationFiled: February 19, 2013Publication date: January 15, 2015Applicant: SUNTORY HOLDINGS LIMITEDInventors: Yoshikazu Tanaka, Yukihisa Katsumoto
-
Publication number: 20150013031Abstract: The present invention relates to methods and compositions for improving the efficiency of Agrobacterium- and Rhizobium-mediated plant cell transformation by use of additional transformation enhancer sequences, such as overdrive or TSS sequences, operably linked to a T-DNA border sequence on a recombinant construct that comprises T-DNA.Type: ApplicationFiled: June 3, 2014Publication date: January 8, 2015Inventors: Larry A. Gilbertson, Xudong Ye
-
Publication number: 20150007363Abstract: The subject invention pertains to novel mutant polynucleotide molecules that encode enzymes that have increased heat stability. These polynucleotides, when expressed in plants, result in increased yield in plants grown under conditions of heat stress. The polynucleotide molecules of the subject invention encode maize endosperm ADP glucose pyrophosphorylase (AGP) and soluble starch synthase (SSS) enzyme activities. Plants and plant tissue bred to contain, or transformed with, the mutant polynucleotides, and expressing the polypeptides encoded by the polynucleotides, are also contemplated by the present invention. The subject invention also concerns methods for isolating polynucleotides and polypeptides contemplated within the scope of the invention. Methods for increasing yield in plants grown under conditions of heat stress are also provided.Type: ApplicationFiled: July 1, 2014Publication date: January 1, 2015Inventors: L. CURTIS HANNAH, THOMAS W. GREENE
-
Publication number: 20140380525Abstract: A transgenic plant comprising a polynucleotide encoding a nitrogen utilization protein operably linked to a PBpr1 promoter is provided. The transgenic plant exhibits increased nitrogen use efficiency, increased biomass and/or increased seed yield. Seeds from such transgenic plants, genetic constructs to prepare such plants, methods of generating and growing transgenic plants are also provided.Type: ApplicationFiled: September 7, 2012Publication date: December 25, 2014Applicant: BAYER CROPSCIENCE AGInventors: Allen Good, Yee Ying Lock, Perrin H. Beatty
-
Publication number: 20140342404Abstract: The present invention concerns polypeptides comprising a variant Fc region. More particularly, the present invention concerns Fc region-containing polypeptides that have altered effector function as a consequence of one or more amino acid modifications in the Fc region thereof.Type: ApplicationFiled: April 10, 2013Publication date: November 20, 2014Applicant: GENENTECH, INC.Inventor: Leonard G. PRESTA
-
Publication number: 20140342450Abstract: Provided are antibodies including human antibodies and antigen-binding portions thereof that specifically bind to CCR2, preferably human CCR2, and that may inhibit CCR2. The present antibodies may bind to the first and/or second extracellular loops of CCR2. Isolated heavy and light chains derived from the antibodies and nucleic acid molecules encoding the antibodies and chains are provided. Methods of making and using the anti-CCR2 antibodies or antigen-binding portions, and compositions comprising these antibodies or antigen-binding portions, including compositions for diagnosis and treatment, are provided. Also provided are gene therapy methods using nucleic acid molecules encoding the heavy and/or light chains that comprise the human anti-CCR2 antibodies or antigen-binding portions thereof.Type: ApplicationFiled: April 3, 2014Publication date: November 20, 2014Applicants: Amgen Fremont Inc., Pfizer Inc.Inventors: Ronald P. Gladue, Bradley T. Keller, Shinji Ogawa, Arvind Rajpal, Laurie A. Tylaska, Shelley Sims Belouski, Larry L. Green, Meina L. Liang
-
Publication number: 20140328994Abstract: A potato cultivar designated E12 is disclosed. The invention relates to the tubers of potato cultivar E12, to the seeds of potato cultivar E12, to the plants of potato E12, to the plant parts of potato cultivar E12, to food products produced from potato cultivar E12, and to methods for producing a potato plant produced by crossing potato cultivar E12 with itself or with another potato variety. The invention also relates to methods for producing a potato plant containing in its genetic material one or more transgenes and to the transgenic potato plants and plant parts produced by those methods. This invention also relates to potato cultivars or breeding cultivars and plant parts derived from potato variety E12, to methods for producing other potato cultivars, lines or plant parts derived from potato cultivar E12 and to the potato plants, varieties, and their parts derived from use of those methods.Type: ApplicationFiled: November 5, 2013Publication date: November 6, 2014Applicant: J.R. SIMPLOT COMPANYInventors: Pete CLARK, Susan Fortier COLLINGE
-
Publication number: 20140328995Abstract: A potato cultivar designated J55 is disclosed. The invention relates to tubers of potato cultivar J55, to seeds of potato cultivar J55, to plants and plant parts of potato cultivar J55, to food products produced from potato cultivar J55, and to methods for producing a potato plant by crossing potato cultivar J55 with itself or with another potato variety. The invention also relates to methods for producing a transgenic potato plant and to the transgenic potato plants and parts produced by those methods. This invention also relates to potato plants and plant parts derived from potato cultivar J55, to methods for producing other potato plants or plant parts derived from potato cultivar J55 and to the potato plants and their parts derived from use of those methods. The invention further relates to hybrid potato tubers, seeds, plants and plant parts produced by crossing potato cultivar J55 with another potato cultivar.Type: ApplicationFiled: April 29, 2014Publication date: November 6, 2014Applicant: J.R. SIMPLOT COMPANYInventors: Pete Clark, Susan Fortier Collinge
-
Publication number: 20140322221Abstract: The present application describes engineered antibodies, with three or more functional antigen binding sites, and uses, such as therapeutic applications, for such engineered antibodies.Type: ApplicationFiled: March 28, 2014Publication date: October 30, 2014Applicant: Genentech, Inc.Inventors: Kathy L. MILLER, Leonard G. PRESTA
-
Publication number: 20140322218Abstract: The present invention provides to a antibody construct comprising a first human binding domain capable of binding to human CDH19 on the surface of a target cell and a second domain capable of binding to human CD3 on the surface of a T cell. Moreover, the invention relates to a nucleic acid sequence encoding the antibody construct, a vector comprising said nucleic acid sequence and a host cell transformed or transfected with said vector. Furthermore, the invention relates a process for the production of the antibody construct of the invention, a medical use of said antibody construct and a kit comprising said antibody construct.Type: ApplicationFiled: January 27, 2014Publication date: October 30, 2014Applicant: AMGEN RESEARCH (MUNICH) GMBHInventors: Shouhua Xiao, Zheng Pan, Dineli Wickramasinghe, Shawn Jeffries, Chadwick T. King, Brian Mingtung Chan, Peter Kufer, Ralf Lutterbüse, Tobias Raum, Patrick Hoffmann, Doris Rau, Roman Kischel, Bryan Lemon, Holger Wesche
-
Publication number: 20140322812Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system and methods of modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms.Type: ApplicationFiled: April 24, 2014Publication date: October 30, 2014Applicant: Intrexon CorporationInventors: Subba Reddy PALLI, Mohan Basavaraju KUMAR
-
Publication number: 20140308271Abstract: The present invention relates to antibodies or fragments thereof that bind to TL1A. More specifically, the present invention relates to an antibody or fragment thereof that binds to TL1A comprising a heavy chain CDR1 comprising the amino acid sequence of SEQ ID NO: 51, and/or a heavy chain CDR2 comprising the amino acid sequence of SEQ ID NO: 52, and/or a heavy chain CDR3 comprising the amino acid sequence of SEQ ID NO: 53; and/or comprising a light chain CDR1 comprising the amino acid sequence of SEQ ID NO: 54, and/or a light chain CDR2 comprising the amino acid sequence of SEQ ID NO: 55 and/or a light chain CDR3 comprising the amino acid sequence of SEQ ID NO: 56.Type: ApplicationFiled: January 2, 2014Publication date: October 16, 2014Applicant: GLENMARK PHARMACEUTICALS S.A.Inventors: ANTOINE ATTINGER, JONATHAN ALBERT BACK, STANISLAS BLEIN, RAMI LISSILAA, DARKO SKEGRO
-
Publication number: 20140304853Abstract: Disclosed herein are methods and compositions for parallel or sequential transgene stacking in plants to produce plants with selected phenotypes.Type: ApplicationFiled: April 2, 2014Publication date: October 9, 2014Inventors: W. Michael Ainley, Dmitry Y. Guschin, Matthew Hayden, Daniel Isenegger, John Mason, Jeffrey C. Miller, Joseph F. Petolino, Yidong Ran, Tim Sawbridge, German Spangenberg, Steven R. Webb
-
Publication number: 20140298543Abstract: The invention provides compositions and methods for manipulating the exchange of water and/or carbon dioxide (CO2) through plant stomata by controlling CO2 sensor genes. The invention provides compositions and methods for enhancing or optimizing biomass accumulation in a plant. The invention provides compositions and methods for opening or closing a stomatal pore on a guard cell in the epidermis of a plant. The invention provides compositions and methods for increasing or decreasing oxygenation efficiency and/or carbon fixation in a guard cell in the epidermis of a plant by manipulating expression of a ribulose-1,5-bisphosphate carboxylase/oxygenase. The invention provides promoters for regulating expression of a nucleic acid in a plant guard cell.Type: ApplicationFiled: March 5, 2014Publication date: October 2, 2014Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Julian I. SCHROEDER, Maria ISRAELSSON-NORDSTROM, Josef M. KUHN, Yingzhen YANG, Honghong HU, Aurelien BOISSON-DERNIER
-
Publication number: 20140259220Abstract: The present invention provides methods for increasing plant biomass and plant seed yield through overexpression of a PHB gene. Also provided are plants with increased biomass and seed yield comprising overexpression of a PHB gene produced by such methods. Plants described herein may be used, for example, for improved production of biofuels.Type: ApplicationFiled: March 5, 2014Publication date: September 11, 2014Applicant: The Texas A&M University SystemInventor: Shuhua Yuan
-
Publication number: 20140256930Abstract: An object of the present invention is to provide a method for converting the coenzyme dependency of enzymes of the medium-chain dehydrogenase/reductase (MDR) family. A further object of the present invention is to provide enzyme variants of the MDR family whose coenzyme dependency is converted by the conversion method and a method for enzymatically producing optically active alcohols using the enzymes. The present inventors developed a novel enzyme conversion method for converting the coenzyme dependency of enzymes of the MDR family, rationally designed enzyme variants that are altered by the enzyme conversion method to be able to use NADPH as a coenzyme from a useful enzyme of the MDR family that uses NADH as a coenzyme, and actually provide variants having such an ability.Type: ApplicationFiled: June 27, 2012Publication date: September 11, 2014Applicant: KANEKA CORPORATIONInventors: Shinichi Yoshida, Shunichi Taira, Masakatsu Nishihachijyo, Masutoshi Nojiri, Shigeru Kawano
-
Publication number: 20140237689Abstract: The present invention provides metabolic regulators, which are proteins (such as fusion proteins, truncated proteins or full-length proteins) that bind to specific metabolites and which can be used to control the availability of the metabolites in cells, particularly plant cells. Proteins of the invention include one or more metabolic regulator proteins, can be truncated or full length, can further comprise a transmembrane domain or lipoylation site or can further comprise a transit peptide. Metabolic regulators of the invention can be soluble, e.g., cytosolic soluble, can be anchored to a biological membrane or can be organelle targeted or apoplastic targeted. The present invention also provides nucleic acid molecules encoding the metabolic regulators, methods of making the nucleic acid molecules, methods for making transformed organisms, including plants, photosynthetic organisms, microbes, invertebrates, and vertebrates, and methods for controlling availability of metabolites to a host cell.Type: ApplicationFiled: May 2, 2014Publication date: August 21, 2014Applicant: PLANT SENSORY SYSTEMS, LLCInventors: Frank J. Turano, Kathleen A. Turano
-
Patent number: 8802931Abstract: The present invention provides transgenic plants transformed with exogenous nucleic acid encoding a Dunaliella plasma membrane (PM)-ATPase. The transgenic plant has increased tolerance to salt as compared to a corresponding non-transgenic plant. The present invention also provides nucleic acids encoding a chimeric PM-ATPase, which comprise a first portion encoding a plant PM-ATPase or a fragment thereof, and a second portion encoding a Dunaliella PM-ATPase or a fragment thereof. The present invention also discloses a method of producing a transgenic plant having an increased tolerance to salt as compared to a corresponding non-transgenic plant, a method of modifying a plant capacity to survive salt shock, and a method of modifying plant recovery after exposure to salt stress, by introducing into one or more cells of a plant an exogenous nucleic acid encoding a Dunaliella PM-ATPase.Type: GrantFiled: September 1, 2005Date of Patent: August 12, 2014Assignee: Yeda Research and Development Co. Ltd.Inventors: Uri Pick, Orna Livneh, Eli Khayat, Rina Walther, Avi Gabai
-
Publication number: 20140223605Abstract: This invention relates generally to a plant cell with enhanced nitrogen use efficiency and/or increased biomass production as compared to a corresponding non-transformed wild type plant cell by increasing or generating one or more activities of polypeptides associated with enhanced nitrogen use efficiency in plants.Type: ApplicationFiled: January 9, 2014Publication date: August 7, 2014Applicant: BASF Plant Science GmbHInventors: Piotr Puzio, Oliver Bläsing, Oliver Thimm, Gerhard Ritte, Hardy Schön
-
Publication number: 20140208462Abstract: The present disclosure relates, in some embodiments, to compositions, organisms, systems, and methods for expressing a gene product in a plant using a expression control sequence (ECS) operable in monocots and/or dicots. For example, (i) an isolated nucleic acid may comprise an ECS (e.g., a sugarcane bacilliform virus promoter) and, optionally, an exogenous nucleic acid (ExNA) operably linked to the ECS; (ii) an expression vector may comprise an ECS; an ExNA; and, optionally, a 3? termination sequence, wherein the ECS has promoter activity sufficient to express the ExNA in at least one monocot and at least one dicot; (iii) a microorganism, plant cell, or plant may comprise an isolated nucleic acid; (iv) a method for constitutively expressing an ExNA in a plant (e.g.Type: ApplicationFiled: February 20, 2014Publication date: July 24, 2014Applicant: THE TEXAS A&M UNIVERSITY SYSTEMInventors: Mona DAMAJ, T. Erik MIRKOV
-
Publication number: 20140206035Abstract: Provided are isolated polypeptides having glucoamylase activity, catalytic domains, and polynucleotides encoding the polypeptides, catalytic domains. Also provided are nucleic acid constructs, vectors and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains.Type: ApplicationFiled: August 24, 2012Publication date: July 24, 2014Inventors: Tianqi Sun, Ming Li
-
Publication number: 20140196174Abstract: The present invention relates to transgenic potato plants having an increased resistance against Phytophthora infestans and a comparable yield of potato tubers compared with the wildtype potato plants, wherein the blb1-gen and blb2-gen are integrated within a specific genetic background into the potato plant.Type: ApplicationFiled: May 24, 2012Publication date: July 10, 2014Applicant: BASF PLANT SCIENCE COMPANY GMBHInventors: Holger Schultheiss, Timo Böhme
-
Publication number: 20140178561Abstract: Materials and methods are provided for making plants (e.g., Solanum varieties) with decreased accumulation of reducing sugars and acrylamide in cold-stored potatoes, specifically, by making TALE-nuclease-induced mutations in genes encoding vacuolar invertase.Type: ApplicationFiled: December 20, 2013Publication date: June 26, 2014Applicant: CellectisInventors: Luc Mathis, Daniel F. Voytas, Feng Zhang, Benjamin Clasen, William Haun, Thomas Stoddard
-
Publication number: 20140173776Abstract: The present invention refers to method for producing a transgenic plant with increased herbicide tolerance or resistance as compared to a corresponding non-transformed wild type plant, comprising transforming a plant cell or a plant cell nucleus or a plant tissue with a nucleic acid molecule encoding an Alopecurus cytochrome P450 monooxygenase, as well as to the nucleic acid, and plants with increased herbicide tolerance or resistance comprising the nucleic acid of the invention.Type: ApplicationFiled: August 29, 2013Publication date: June 19, 2014Applicant: BASF SEInventors: Stefan TRESCH, Doreen SCHACHTSCHABEL, Maciej PASTERNAK, Liliana PARRA RAPADO, Jens LERCHL, Thomas MIETZNER, Martin LaFOREST
-
Publication number: 20140147436Abstract: The present invention concerns polypeptides comprising a variant Fc region. More particularly, the present invention concerns Fc region-containing polypeptides that have altered effector function as a consequence of one or more amino acid modifications in the Fc region thereof.Type: ApplicationFiled: July 19, 2013Publication date: May 29, 2014Applicant: GENENTECH, INC.Inventor: Leonard G. PRESTA
-
Patent number: 8710207Abstract: The present disclosure relates, in some embodiments, to compositions, organisms, systems, and methods for expressing a gene product in a plant using a expression control sequence (ECS) operable in monocots and/or dicots. For example, (i) an isolated nucleic acid may comprise an ECS (e.g., a sugarcane bacilliform virus promoter) and, optionally, an exogenous nucleic acid (ExNA) operably linked to the ECS; (ii) an expression vector may comprise an ECS; an ExNA; and, optionally, a 3? termination sequence, wherein the ECS has promoter activity sufficient to express the ExNA in at least one monocot and at least one dicot; (iii) a microorganism, plant cell, or plant may comprise an isolated nucleic acid; (iv) a method for constitutively expressing an ExNA in a plant (e.g.Type: GrantFiled: May 10, 2011Date of Patent: April 29, 2014Assignee: The Texas A&M University SystemsInventors: T. Erik Mirkov, Jong Won Park, San-Ji Gao
-
Publication number: 20140115736Abstract: The present invention relates to diploid, fertile, self-compatible and essentially homozygous potato lines, wherein said lines comprise an agronomically desirable trait such as vigour. The invention further relates to methods for producing such plants and to hybrid seeds obtained by crossing such homozygous potato lines and to potato plants grown from said seed.Type: ApplicationFiled: April 20, 2012Publication date: April 24, 2014Inventors: Willem Hendrik Lindhout, Teunis Philippus Schotte, Richard Gerardus Franciscus Visser, Herman Johannes Van Eck, Ronaldus Cornelis Bernardus Hutten
-
Publication number: 20140090111Abstract: The invention provides fusion proteins comprising at least two fluorescent proteins, with the fluorescent proteins emitting different wavelengths of light from one another, at least one plant hormone binding domain that changes three-dimensional conformation upon specifically binding to a plant hormone, and two linker peptides, with the first linker linking the first fluorescent protein to the N-terminus of the plant hormone binding domain and the second linker linking the second fluorescent protein to the C-terminus of the plant hormone binding domain. The invention also provides for methods of using the fusion proteins of the present invention and nucleic acids encoding the fusion proteins.Type: ApplicationFiled: September 5, 2013Publication date: March 27, 2014Applicant: Carnegie Institution of WashingtonInventors: Wolf B. Frommer, Alexander M. Jones
-
Publication number: 20140082763Abstract: A potato cultivar designated ‘FL 2322’ is disclosed. The invention relates to tubers and seeds of potato cultivar ‘FL 2322’, to plants of potato cultivar ‘FL 2322’, to plant parts of potato cultivar ‘FL 2322’ and to methods for producing progeny of potato cultivar ‘FL 2322’. The invention relates to methods for producing a potato plant containing in its genome one or more transgenes and to the transgenic potato plants and plant parts produced by those methods. This invention relates to potato cultivars or breeding cultivars and plant parts derived from potato variety ‘FL 2322’, to methods for producing other potato cultivars, lines or plant parts derived from potato cultivar ‘FL 2322’ and to potato plants, varieties, and their parts derived from use of those methods. The invention further relates to hybrid potato tubers, seeds, plants and plant parts produced by crossing potato cultivar ‘FL 2322’ with another potato cultivar.Type: ApplicationFiled: September 14, 2012Publication date: March 20, 2014Applicant: FRITO-LAY NORTH AMERICA, INC.Inventor: Robert W. Hoopes
-
Publication number: 20140082762Abstract: A potato cultivar designated ‘FL 2312’ is disclosed. The invention relates to tubers and seeds of potato cultivar ‘FL 2312’, to plants of potato cultivar ‘FL 2312’, to plant parts of potato cultivar ‘FL 2312’ and to methods for producing progeny of potato cultivar ‘FL 2312’. The invention relates to methods for producing a potato plant containing in its genome one or more transgenes and to the transgenic potato plants and plant parts produced by those methods. This invention relates to potato cultivars or breeding cultivars and plant parts derived from potato variety ‘FL 2312’, to methods for producing other potato cultivars, lines or plant parts derived from potato cultivar ‘FL 2312’ and to potato plants, varieties, and their parts derived from use of those methods. The invention further relates to hybrid potato tubers, seeds, plants and plant parts produced by crossing potato cultivar ‘FL 2312’ with another potato cultivar.Type: ApplicationFiled: September 14, 2012Publication date: March 20, 2014Applicant: FRITO-LAY NORTH AMERICA, INC.Inventor: Robert W. Hoopes
-
Publication number: 20140075600Abstract: The present invention relates to a valencene synthase, to a nucleic acid encoding such valencene synthase, to a host cell comprising said encoding nucleic acid sequence and to a method for preparing valencene, comprising converting farnesyl diphosphate to valencene in the presence of a valencene synthase according to the invention.Type: ApplicationFiled: December 15, 2010Publication date: March 13, 2014Applicant: Isobionics B.V.Inventors: Jihane Achkar, Theodorus Sonke, Martinus Julius Beekwilder, Hendrik Jan Bouwmeester, Hendrik Jan Bosch
-
Publication number: 20140068812Abstract: The present invention discloses regulatory sequences, promoters and terminators, and their use in plants. The regulatory sequences can be used to make gene constructs that include a gene not natively associated with the regulatory sequences. Methods to use the regulatory sequences with antisense constructs or functional RNAs are disclosed. Methods to use the regulatory sequences, promoter or terminator, independently of each other are also disclosed. Methods to use the regulatory sequences to improve plant growth and production such as increased biomass, increased yield and increased tolerance to abiotic or biotic stresses are also disclosed.Type: ApplicationFiled: April 23, 2012Publication date: March 6, 2014Applicant: PLANT SENSORY SYSTEMS, LLCInventors: Frank J. Turano, Kathleen A. Turano